Allarity Therapeutics, Inc.
ALLR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860657
No open-market purchases or sales by Allarity Therapeutics, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Allarity Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 4 | 4 | 0 |
| Shares | 58.1K | 38.8K | −19.3K (−33.3%) |
| Value | $31.8K | $11.7K | −$20.1K (−63.2%) |
New holders (2)
Institutions that held Allarity Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 33,026 | $9.94K | 0.00% |
| Morgan Stanley | 7 | $2 | 0.00% |
Sold out (2)
Institutions that held Allarity Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 37,550 | $20.7K |
| Virtu Financial LLC | 15,005 | $8.00K |